Phathom Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +8,001.5% | +216.9% | |
| – | – | +3,650.0% | +73.7% | +19.0% | -73.1% | +4,674.3% | +183.4% | |
| – | – | – | – | – | – | +9,080.4% | +222.6% | |
| – | +496,255.0% | -1.1% | -26.3% | -1.2% | -30.2% | -31.7% | -3.8% | |
| – | +476.3% | +296.3% | +128.0% | +61.0% | +16.8% | +146.5% | -3.8% | |
| – | +8,570.6% | +18.0% | +7.3% | +27.7% | -2.3% | +93.5% | -3.8% | |
| – | – | – | – | – | – | – | – | |
| – | +32,030.8% | +9.7% | +48.2% | +302.3% | +53.7% | +71.6% | -5.4% | |
| – | – | – | – | – | – | – | – | |
| – | -349,230.8% | – | -0.9% | +500.4% | +65.2% | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.